Post by the Scribe on Aug 31, 2020 1:29:40 GMT
waits weeks before the election to do something
Last month, I took on Big Pharma. You think that’s easy? It’s not. And signed orders that will massively lower the cost of your prescription drugs and give critically ill patients access to life-saving cures. We passed the decades-long awaited right-to-try. Right-to-try.
President Trump announced executive orders to lower drug prices on July 24, but health policy experts say they will likely offer only minimal relief, if any. The most talked-about one would tie certain drug prices to the less expensive prices in other countries. But this pertains to only Medicare Part B, and the order hasn’t been implemented. Instead, Trump said he’d give pharmaceutical executives time to come up with an alternative plan; if there was no deal by a deadline (which came and went this week), he’d implement the executive order. There’s no sign yet that the order has been implemented.
www.npr.org/2020/07/24/895290378/trump-signs-executive-orders-on-drug-prices
www.npr.org/2020/08/07/899937565/all-bark-and-no-bite-trump-holds-prescription-drug-pricing-order-in-search-of-de
Trump signed into law the Right to Try Act in 2018, which allows patients with life-threatening diseases or conditions, and who have already exhausted all approved treatment options, to access certain experimental treatments still undergoing Food and Drug Administration review. But according to one estimate, fewer than a dozen patients have benefited. Patients already have access to experimental drugs through alternate expanded-access programs at the FDA, which were started by previous administrations.
Nell Greenfieldboyce
NPR Science Desk Correspondent
Last month, I took on Big Pharma. You think that’s easy? It’s not. And signed orders that will massively lower the cost of your prescription drugs and give critically ill patients access to life-saving cures. We passed the decades-long awaited right-to-try. Right-to-try.
President Trump announced executive orders to lower drug prices on July 24, but health policy experts say they will likely offer only minimal relief, if any. The most talked-about one would tie certain drug prices to the less expensive prices in other countries. But this pertains to only Medicare Part B, and the order hasn’t been implemented. Instead, Trump said he’d give pharmaceutical executives time to come up with an alternative plan; if there was no deal by a deadline (which came and went this week), he’d implement the executive order. There’s no sign yet that the order has been implemented.
www.npr.org/2020/07/24/895290378/trump-signs-executive-orders-on-drug-prices
www.npr.org/2020/08/07/899937565/all-bark-and-no-bite-trump-holds-prescription-drug-pricing-order-in-search-of-de
Trump signed into law the Right to Try Act in 2018, which allows patients with life-threatening diseases or conditions, and who have already exhausted all approved treatment options, to access certain experimental treatments still undergoing Food and Drug Administration review. But according to one estimate, fewer than a dozen patients have benefited. Patients already have access to experimental drugs through alternate expanded-access programs at the FDA, which were started by previous administrations.
Nell Greenfieldboyce
NPR Science Desk Correspondent